Addition of inhaled corticosteroids to long-acting β2-agonists does not improve outcomes in stable COPD

Aaron, Shawn D.
March 2010
ACP Journal Club;3/16/2010, Vol. 152 Issue 3, p4
Academic Journal
The article focuses on a medical research related to effectiveness and safety of inhaled corticosteroids and long-acting β2-agonists (LABA) combined therapy in patients with stable chronic obstructive pulmonary disease (COPD). Combined LABA/ICS therapy reduced risk for moderate COPD exacerbations in comparison of LABA alone and increased the risk of Risks for pneumonia and viral respiratory infections. Combined LABA/ICS therapy is not more effective than LABAs alone.


Related Articles

  • Treating COPD in the RealWorld. Calverley, Peter M. A. // JAMA: Journal of the American Medical Association;9/17/2014, Vol. 312 Issue 11, p1101 

    An introduction to a study about the efficacy of using long-acting beta-agonists (LABA) alone or in combination with inhaled corticosteroids (ICS) in the treatment of chronic obstructive pulmonary disease (COPD) in elderly patients is presented.

  • THE USE OF LONG-ACTING β2-AGONISTS AS MONOTHERAPY IN CHILDREN AND ADULTS. Camp, Pat G.; Tingting Zhang; Smith, M. Anne; Carleton, Bruce C. // Journal of Population Therapeutics & Clinical Pharmacology;2013, Vol. 20 Issue 1, pe1 

    Background In asthma, it is recommended that long-acting β2-agonists (LABAs) not be used as monotherapy, but, be used with inhaled corticosteroids (ICS) to minimize the risk of serious adverse events. Objective To test the hypothesis that if clinical recommendations were followed, LABA...

  • Changes in recommended treatments for mild and moderate asthma. Redding, Gregory J.; Stoloff, Stuart W. // Journal of Family Practice;Sep2004, Vol. 53 Issue 9, p692 

    This article reviews the 2002 National Asthma Education and Prevention Program (NAEPP) recommendations for the use of controlled medications for asthma, including the relative effectiveness of inhaled corticosteroids (ICSs) versus other controller medications, safety of long-term ICS use in...

  • COPD combination therapy questioned.  // Independent Nurse;11/2/2009, p15 

    The article discusses a Dutch study concerning the addition of long-acting beta-agonists (LABAs) to corticosteroid therapy for chronic obstructive pulmonary disease (COPD). The findings of the study negate an analysis of the Toxoplasmosis, Rubella, Cytomegalovirus and Herpes Simplex (TORCH)...

  • The WISDOM of inhaled corticosteroids in COPD. Halpin, David M. G.; Quint, Jennifer K. // Thorax;Dec2014, Vol. 69 Issue 12, p1071 

    The article focuses on a study showing the effective role of inhaled corticosteroids (ICS) along with bronchodilators in patients with Chronic obstructive pulmonary disease (COPD) reducing the risk of exacerbations. Topics discussed include WISDOM study conducted to investigate the role of ICS,...

  • Pneumonia and inhaled corticosteroids in COPD. Jabbar, Avais // Thorax;Sep2014, Vol. 69 Issue 9, p872 

    The article focuses on a study on the association between increased risk of pneumonia in patient with chronic obstructive pulmonary disease (COPD) and combined treatment of long-acting β2-agonists and corticosteroids. It says that the risks of pneumonia and related events in patients treated...

  • COPD: Long-acting beta agonists canter survival benefit in older patients.  // Medical Economics;6/10/2011, Vol. 88 Issue 11, p65 

    The article focuses on the result of a study which confirms the survival advantage of long-acting beta agonists for treatment of chronic obstructive pulmonary diseases (COPD) in older patients.

  • Should tiotropium be a maintenance asthma medication?  // Primary Care Reports;Jan2011 Clinical Briefs in Primary, Vol. 16 Issue 1, p2 

    The article reports on a research study on asthmatics treated either with, or in combination with inhaled corticosteroids (ICS), tiotropium (TIO), or long-acting beta agonist salmeterol (LABA), concluding that TIO in conjunction with ICS is a good maintenance medication for asthma.

  • Comparison of the Efficacy of Nebulised Budesonide with Parenteral Corticosteroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Mirici, A.; Meral, M.; Akgun, M. // Clinical Drug Investigation;2003, Vol. 23 Issue 1, p55 

    Objective: To compare the efficacy and safety of nebulised budesonide and systemic corticosteroid in the treatment of acute exacerbations of chronic obstructive pulmonary disease (COPD). Design: Randomised, double-blind, placebo-controlled, parallel-group trial. Patients and interventions: A...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics